Most recent hypertension related innovations
At Heartery , we monitor carefully the most exciting developments in blood pressure related innovations. They are presented below. It is a long read, over 5,000 words, as a lot is going on in hypertension and hypotension related measuring, management, and control.
Table of Contents:
UNIVERSITIES
Queen Mary University of London : new imaging technique to diagnose of rare hypertension
美国哥伦比亚大学 & Université Paris-Est Créteil (UPEC) : new ultrasound device to reduce blood pressure
爱尔兰国立高威大学 , UK: ‘shape-shifting’ implanted medical device for continuous blood pressure monitoring
英国剑桥大学 : AI to personalise CAD prevention
St. George's University : AI to examine for signs of high blood pressure in eyes
美国波士顿大学 : AI to match blood pressure lowering medicines
加拿大多伦多大学 : earbuds to monitor blood pressure
Queen Mary University of London : new CT scan technique cures high blood pressure in some patients
美国加州大学洛杉矶分校 : machine learning to treat hypertension
英国伦敦大学学院 : sound wave torpedo to lower blood pressure
美国加州大学伯克利分校 : 3D printed innovation to revolutionize blood pressure monitoring
STARTUPS
Health Gauge: New smartwatch to track blood pressure gets closer to FDA approval
AI device by Medasense Biometrics Ltd. monitors blood pressure during surgery to help manage pain
Smart ring by Senbiosys aims to monitor blood pressure from your finger
Smartphone app by Biospectal SA propels global accessibility in hypertension management
MID MARKET
Movano Health CEO announces breakthrough blood pressure monitoring technology
Aktiia unveils light-based blood pressure monitoring bracelet
SKYLAB ring to monitor blood pressure via heart rhythm is approved in Korea
FloPatch by Flosonics Medical enhances blood pressure monitoring in sepsis treatment
NuraLogix Corporation : blood pressure management via a video selfie
BIG TECH
Fitbit (now part of Google) filed a patent for wearable blood pressure measuring
苹果 to use lasers in its non-invasive blood glucose monitoring in watches
华为 to launch new blood pressure measurement smartwatch in second half of 2023
OPPO unveils innovative wrist-measuring blood pressure device
苹果 has won a patent for a low profile blood pressure measuring
三星电子 's revolutionary OLED screen promises to monitor blood pressure
Samsung Electronics America improves blood pressure monitoring at Galaxy 4 and 5
UNIVERSITIES
Queens Mary University of London: new imaging technique to diagnose of rare hypertension
Researchers at?Queen Mary University of London?have identified an imaging technique that could help diagnose primary aldosteronism, a rare cause of hypertension that accounts for 20% to 25% of treatment-resistant cases. The method, known as metomidate positron emission tomography computed tomography (MTO), uses a PET radiotracer in combination with CT imaging. MTO was at least as accurate as existing diagnostic approaches, which are invasive and time-consuming, and could be more widely adopted in hospitals.
Columbia University & UPEC: new ultrasound device to reduce blood pressure
A new?study?conducted by researchers at?Columbia University?in the USA and the?Université Paris-Est Créteil (UPEC)?in France has found that a device used in an outpatient procedure called ultrasound renal denervation can significantly reduce daytime ambulatory blood pressure in middle-aged individuals with hypertension. The device resulted in a consistent reduction of daytime ambulatory blood pressure by an average of 8.5 points,?SciTechDaily?reports. This is significant as about one-third of hypertensive patients are unable to control their blood pressure despite lifestyle changes and medications. The treatment will be evaluated by the?FDA?in the coming months and could be offered as an adjunct to medication therapy and lifestyle changes for patients with uncontrolled hypertension.
“Renal ultrasound could be offered to patients who are unable to get their blood pressure under control after trying lifestyle changes and drug therapy, before these events occur.” says?Ajay Kirtane, MD, professor of medicine at?Columbia University Vagelos College of Physicians and Surgeons?and co-leader of the study.
University of Galway, UK: ‘shape-shifting’ implanted medical device for continuous blood pressure monitoring
Researchers from the?SMARTSHAPE-project?blood pressure monitoring, Hospimedica?reports?were awarded €4.4 million by the European Union for the development of a disruptive technology sensor. Hypertension is responsible for more than nine million deaths annually worldwide, and long-term monitoring is crucial for high-risk patients. However, there is currently no clinically accepted method for continuous beat-to-beat blood pressure monitoring outside of the hospital setting. The new device aims to offer a medical-grade, user-friendly, and minimally invasive solution for continuous blood pressure monitoring.
“Blood pressure monitoring will represent the first SMARTSHAPE application. However, the potential of this sensing solution goes significantly beyond BP monitoring,” said Dr.?Sandra Ganly, Senior Research Fellow in Cardiovascular Risk Factor Research at the?University of Galway.
Cambridge University: AI to personalise CAD prevention
Researchers have developed an artificial intelligence model that can identify a patient's inherited risk of?coronary artery disease (CAD)?and provide personalized recommendations for reducing their blood pressure or?low-density lipoprotein (LDL)?cholesterol levels,?Health Analytics, LLC?reports. The causal AI tool was validated in a recent study presented at the?American College of Cardiology's Annual Scientific Session. According to the?Centers for Disease Control and Prevention, CAD is the most common type of heart disease in the US. The AI tool was designed to help explain why a patient is at risk of CAD, how to reduce that risk, and how much a patient will benefit from certain actions designed to lower the risk. The researchers combined causal AI with polygenic risk scores for CAD to identify and quantify how blood pressure and LDL levels, two major modifiable heart disease risk factors, can provide guidance on how patients can combat their inherited risk of the disease.
“The breakthrough of causal AI is that it quantifies all of these recommendations and personalizes them so each person can know exactly how much they need to lower their LDL, their blood pressure or both to overcome their inherited risk,” said Dr?Brian Ference, Professor and Director of Translational Therapeutics at the?University of Cambridge.
University of Toronto: Earbuds to monitor blood pressure
University of Toronto's assistant professor in the department of computer science, Dr?Alex Mariakakis, has received a seed grant from?TRANSFORM HF?for his project, "Accessible Blood Pressure Estimation with Earbuds." Dr Mariakakis and his team hope to use earbuds to monitor blood pressure in patients with heart failure. The earbuds' in-ear microphone will collect audio and transmit it to a smartphone via Bluetooth, which will analyze heart sounds to determine the patient's blood pressure,?Uni of T?reports. Unlike traditional blood pressure cuffs, the earbuds can be worn consistently and will facilitate regular assessment of blood pressure, aiding self-management of heart failure. The technology will work on any earbud with an in-ear microphone.
Dr. Alex Mariakakis: “Eventually, we want to deploy this in clinic. This will help us to answer all sorts of questions related to how we would integrate this kind of technology into healthcare.”
Queen Mary University of London: CT scan technique cures high blood pressure in some patients
A study led by researchers from?Queen Mary University of London,?Barts Health NHS Trust, and?Cambridge University Hospitals NHS Foundation Trust?has utilized a new CT scan technique to identify and remove hormone-producing?nodules, curing high blood pressure in some patients,?SciTechDaily?reports. The study, published in?Nature Medicine, involved 128 participants with hypertension caused by a steroid hormone, aldosterone. The novel CT scan uses a radioactive dye to pinpoint nodules, facilitating their safe removal. This method proved as accurate as traditional catheter tests but was quicker and painless. The research could transform hypertension diagnosis and treatment, benefiting one in twenty patients with the condition.
Professor?Morris Brown, co-senior author of the study and Professor of Endocrine Hypertension at Queen Mary University of London, said: “These aldosterone-producing nodules are very small and easily overlooked on a regular CT scan. When they glow for a few minutes after our injection, they are revealed as the obvious cause of Hypertension, which can often then be cured. Until now, 99% are never diagnosed because of the difficulty and unavailability of tests. Hopefully, this is about to change.”Figure
UCLA: Machine learning to treat hypertension
UCLA researchers have found that a machine-learning technique called?"causal forest"?could make treating patients with high blood pressure about five times more efficient than current clinical practice. The?study?is published in the peer-reviewed?International Journal of Molecular Epidemiology and Genetics. The technique allows for personalized predictions of how each individual will benefit from a given treatment,?Newswise?reports. The study used data from nearly 10,700 people from two trials and estimated the effect of individualized treatment on reducing adverse cardiovascular outcomes. Results showed that the high-benefit approach, targeting those with high estimated health benefits from lowering blood pressure, outperformed the traditional high-risk approach by nearly 8 percentage points.
“The findings of our study shed light on a powerful machine learning algorithm that enables us to identify individuals who would benefit the most from strict blood pressure control, which can be a crucial element in achieving the precision medicine,” said senior author Dr.?Yusuke Tsugawa, MD, PhD, an associate professor of medicine in the division of general internal medicine and health services research at the?David Geffen School of Medicine at UCLA?and of health policy and management at the?UCLA Fielding School of Public Health.
University College London: sound wave torpedo to lower blood pressure
Researchers at?UCL?have developed a torpedo-like device that uses ultrasound waves to lower high blood pressure,?according?to?The Daily Mail International. The diminutive device, when placed in the renal artery, zaps nerves in the artery walls, resulting in a significant drop in blood pressure. High blood pressure, affecting one in three adults in the UK, often leads to severe health consequences, including heart failure, stroke, and irreversible kidney damage. The current treatments, lifestyle changes and medication, often prove insufficient. This new approach could provide an effective alternative for hypertension management, targeting the misfiring nerves in the kidneys.
Professor?Bryan Williams, a specialist in hypertension at University College London Hospitals NHS Foundation Trust ?and President of the?International Society of Hypertension, said: "It's good to see this collation of data from these well-conducted studies of ultrasound-based renal denervation. It confirms what individual studies have shown, that this technique lowers blood pressure, on average, by the amount of blood pressure lowering we would expect to see with a blood-pressure lowering drug.”
St George University: AI to examine for signs of high blood pressure in eyes
St. George's University-led research has uncovered 119 genetic factors affecting the size and shape of blood vessels in the back of the eye, according to the?News Medical Life Science. The findings, published in?PLOS Genetics, suggest that an increase in arterial "twisting" could lead to hypertension and heart disease. The eyes offer a unique window into the body, with previous studies linking the shape and size of retinal blood vessels to health conditions like high blood pressure, heart disease, diabetes, and obesity. This latest study leverages artificial intelligence technology to analyze retinal images from nearly 53,000 participants of the UK Biobank study, enabling the automatic distinction of blood vessel types, as well as measurement of vessel width and twisting. The research was funded by the?Medical Research Council?and the?British Heart Foundation.
Professor?Christopher Owen, Head of Chronic Disease Epidemiology at St George's, University of London said: "Retinal imaging is already a mainstay in high-street optometrists. Our AI analysis of these images as part of routine eye checks could easily be done as part of a health check to identify those at high risk of developing high blood pressure or heart disease and in need of early intervention."
领英推荐
Boston University: AI to match blood pressure lowering medicines
A novel artificial intelligence program could become a game-changer in hypertension treatment,?Medical Express?reports?with reference to?Boston University. This groundbreaking?data-driven model, jointly created by Boston University data scientists and physicians, aims to provide real-time hypertension treatment advice personalized to individual patients. Leveraging electronic health record data, the model suggests optimal medications based on a patient's characteristics and clinical history. The team's research showed the model's recommendations resulted in a significantly larger reduction in systolic blood pressure compared to the current standard of care, promising an innovative approach to personalized hypertension treatment.
Professor?Ioannis Paschalidis?of the?Boston University College of Engineering, Director of the?Hariri Institute for Computing, Boston University?said "Our data-driven model is not just predicting an outcome, it is suggesting the most appropriate medication to use for each patient."
University of California: 3D printed innovation to revolutionize blood pressure monitoring
According to?an article?published by?Technology Networks, scientists at the University of California have developed a ground-breaking innovation to combat hypertension. A simple, cost-effective clip, in conjunction with a custom smartphone app, provides a reliable blood pressure monitoring system at the user's fingertip. The device's affordability and user-friendliness make it a game changer in managing blood pressure, especially for those in resource-scarce communities. Numerous reports in the media state that the device eliminates the need for calibrations and cuff measurements, bringing reliable and trustworthy readings to the users, and that the?prototype costs $0,8. The research behind the device is?here.
Professor?Edward Wang, Director of the Digital Health Lab at?UC San Diego, said, "Our is a calibration-free system, meaning you can just use our device without touching another blood pressure monitor to get a trustworthy blood pressure reading."
STARTUPS
New smartwatch to track blood pressure gets closer to FDA approval
AI/ML Innovations's subsidiary,?Health Gauge, has completed a blood pressure validation study using its wearable health monitoring solution,?The Phoenix reports. The study, performed by the?University of Alberta's ST Innovations, confirmed Health Gauge's patented AI technology for cuffless blood pressure estimation as accurate and effective, using only electrocardiogram and photoplethysmogram data from the Phoenix watch. The results of the study showed Health Gauge's solution to be at or near the benchmark for regulatory certification as a Medical Device. Health Gauge plans to complete the?FDA?verification process, which would make the Phoenix the only consumer style wearable approved as a Class 2 medical device for blood pressure. The Phoenix also tracks heart rate, heart rate variability, sleep, steps, distance, calories, blood oxygen, temperature, and respiratory rate, making it a full platform for personal health and monitoring with many medical applications.
Bruce Matichuk, CTO of AI/ML Innovations, and Co-founder of Health Gauge Inc. stated, "The next objective for us is completion of the FDA verification process, which would make Health Gauge's Phoenix the only consumer style wearable approved as a Class 2 medical device for blood pressure, and would afford us many significant B2B and direct-to-consumer opportunities."
AI device monitors blood pressure during surgery to help manage pain
An Israeli startup called?Medasense Biometrics Ltd.?has developed an AI-powered device that uses multiple parameters to monitor blood pressure and other physiological data, allowing physicians to adjust the level of pain relief throughout surgery,?NoCamels - Israeli Tech & Innovation News?reports. The PMD-200 device, which connects non-invasively to a patient's finger, records changes in blood volume and circulation, sweat response, peripheral temperatures, and more. It then uses AI to present an easy-to-understand score from zero to 100. By helping anesthesiologists better manage pain during an operation, the device could lead to patients suffering less pain afterwards and being less likely to become addicted to opioids. The PMD-200 device has already been used in over 60,000 procedures globally.
Galit Zuckerman?founded?Medasense Biometrics Ltd.: “It’s the basic nature of humans or animals to try and protect the body when something happens to it. The response includes, among other things, an increase in heart rate, blood pressure, and sweat.”
Smart ring aims to monitor blood pressure from your finger
Senbiosys, the Swiss-based company behind the?Iris Smart Ring, is preparing to release a product that can track blood pressure from the finger,?according?to?Gadgetandwearables.com. Set apart from competitors by its blood pressure tracking capability, this innovation could make health monitoring less cumbersome, eliminating the need for conventional blood pressure monitors. Expected for retail availability in early 2024, the Iris Smart Ring can also monitor heart rate, stress levels, body temperature, and blood oxygen levels. With a slimmer and lighter design, this smart ring seeks to cater to the growing demand for discreet, functional wearable devices.
Smartphone app propels global accessibility in hypertension management
Biospectal SA's novel blood pressure monitoring application,?OptiBP, has been shown in an independent global health study published in?Nature’s NPJ Digital Medicine, to demonstrate significant promise in aiding individuals and expectant mothers in low-resource and remote areas to monitor and manage high blood pressure. This smartphone-based optical solution, capable of delivering clinical-grade blood pressure readings by merely placing a finger on the camera lens for 20 seconds, promises to democratize hypertension management on a global scale,?StreetInsider.com?reports. With hypertension affecting approximately 1.4 billion individuals worldwide, this development is particularly crucial for underserved regions.
Dr.?Fred St. Goar, MD, M.D., Vice Chairman of?Fogarty Innovation?and adjunct professor at the?University of Global Health Equity, affirms: “Validating the effectiveness of paradigm shifting technologies like OptiBP requires ensuring that they are designed for ease-of-use, tested in context and used in an equitable way. This maximizes their impact and potential to leverage technology in democratizing health care access.”
MID-MARKET
Movano CEO announces breakthrough blood pressure monitoring technology
Movano Health, a Silicon Valley-based health technology company, announced its latest breakthrough in blood pressure monitoring technology, Yahoo Finance?reports. The new device promises to be a game-changer in the field of hypertension management. According to Dr?John Mastrototaro, Movano Health CEO, the device offers a non-invasive and continuous way to monitor blood pressure, which is especially beneficial for people with hypertension. The device uses artificial intelligence algorithms to analyze blood pressure data and provides personalized recommendations to users. The CEO of Movano Health also stated that the technology is undergoing clinical trials and is expected to receive FDA approval later this year. The device is set to hit the market in the second quarter of 2024.
Aktiia unveils light-based blood pressure monitoring bracelet
Swiss-based company?Aktiia?has unveiled an innovative bracelet that uses photoplethysmography (PPG), a light-based technique, to estimate blood pressure,?Freethink?reports. The comfortable, lightweight device transforms PPG signals into accurate blood pressure readings once calibrated with an inflatable cuff. Data is displayed on a smartphone app via Bluetooth and can be stored on the bracelet for 30 days or on?Aktiia’s cloud server. Despite some limitations, like being ineffective during wearer movement, Aktiia's device has shown promising results across diverse participants. Already available in Europe, Aktiia aims to expand its market to North America soon, potentially enhancing health monitoring and quality of life globally.
Mattia Bertschi, CEO and co-founder of?Aktiia, said, "If the progress Aktiia has seen so far continues, the company hopes their device will ultimately improve the health and quality of life for millions of people globally."
FDA approves an innovative blood pressure monitor
The?FDA?has granted 510(K) clearance to?CardieX Limited's CONNEQT Pulse arterial health monitor, an innovative blood pressure monitor designed for home, clinician, and clinical trial use,?Stockhead?reports. The device provides medical-grade measurements of both brachial blood pressure (pressure at the arm) and central blood pressure (pressure at the aorta/heart), in addition to multiple other vascular health biomarkers. The FDA clearance allows for the expansion of Cardiex 's patented SphygmoCor technology in decentralized clinical trials, remote patient monitoring, and self-monitoring at home. The CONNEQT Pulse offers precise and personalized insights into blood pressure and vascular health, empowering patients and clinicians to make better-informed treatment decisions.
Dr?Craig Cooper, Cardiex CEO, said: “This technology has the potential to truly revolutionize the way hypertension and vascular disease is diagnosed and managed in the future.”
Ring to monitor blood pressure via heart rhythm is approved in Korea
Sky Labs' ring-type heart rhythm monitoring device,?CART-ⅠPlus, has received approval from the?Korean Ministry of Food and Drug Safety?to measure blood pressure. The device offers a convenient, cuffless method to monitor blood pressure, utilizing optical capillary pulse waves,?Korea Biomedical Review?reports. Designed to be worn on the finger, it can continuously monitor blood pressure for 24 hours without additional measures. The device provides accurate data on nighttime blood pressure, morning hypertension, and blood pressure variability, aiding in medication dose adjustments and lifestyle improvement tracking. Sky Labs plans to seek approval from the US?FDA?and European?CE?for the device's blood pressure measurement function.
“Using the MFDS approval as a stepping stone, we are accelerating our progress receiving toward U.S. Food and Drug Administration and European CE approval for CART-ⅠPlus’ blood pressure measurement function,” Sky Labs CEO?Lee Byung-hwan?said.
FloPatch: this wearable enhances blood pressure monitoring in sepsis treatment
El Camino Health, a hospital network in California, becomes the first health system globally to use?FloPatch, a wearable ultrasound technology designed to improve sepsis patient outcomes,?Mountain View Voice?reports. FloPatch monitors blood flow, enabling clinicians to deliver more precise fluid treatment. Developed by?Flosonics Medical, the?FDA-approved device has been piloted at?Fogarty Innovation, a medical technology incubator. FloPatch continuously assesses blood flow in carotid arteries and wirelessly transmits data to a secure iOS app, providing real-time actionable information. The technology helps avoid potentially dangerous fluid overload, with four to five patients per every 10 FloPatch uses benefiting from better care.
Cheryl Reinking, DNP, RN, NEA-BC, DipACLM, chief nursing officer at El Camino Health, said in a statement: “Our nurses have seen firsthand how effective FloPatch is in monitoring the effectiveness of treatment in deteriorating patients, especially those with sepsis and low blood pressure.”
Movano Health secures patents for non-invasive blood pressure monitoring technology
Movano Health, a healthcare solutions company, has been granted three new patents for its radio frequency-enabled health monitoring systems that focus on blood glucose levels, blood pressure, and heart rate, according to?the press release?by Movano Health. The company's proprietary System-on-a-Chip (SoC) aims to provide more accurate, flexible, and cost-effective wearable solutions for non-invasive monitoring without a cuff. The SoC combines multiple antennas and frequencies in a compact integrated circuit designed for blood pressure or glucose monitoring systems. Movano Health tested its wrist-worn wearable featuring the SoC in clinical studies in March 2023.
"We are committed to elevating the standards of wearable health technology and aim to create more accurate, flexible and cost-effective wearable solutions that monitor health metrics, including glucose and blood pressure, non-invasively and without a cuff," said?John Mastrototaro, CEO of Movano Health.
Blood pressure management via a video selfie
NuraLogix Corporation, a pioneer of contactless health monitoring,?is showcasing?its Anura? platform's latest capabilities at MWC 2023 in Barcelona, including the ability to measure cuffless blood pressure using mobile and desktop devices. Anura? is the only video-based contactless health monitoring technology that can provide health risk assessments using a video selfie. It uses NuraLogix's patented Transdermal Optical Imaging (TOI?) technology, which extracts blood flow information from key regions of interest on a person's face and combines it with AI data models developed from tens of thousands of patients with multiple health conditions. The platform delivers results for dozens of health parameters, including heart rate, breathing rate, and cuffless blood pressure, making it a game-changer for managing chronic conditions such as hypertension.
Dr?Keith Thompson, Chief Medical Officer at NuraLogix says: ?Platforms such as Anura allow handset manufacturers and carriers to create or work with additional third parties to deploy digital health solutions that can make a meaningful difference to society.?
BIG TECH
Fitbit filed a patent for wearable blood pressure measuring
Fitbit (now part of Google)?has recently filed a patent for a wearable blood pressure measuring functionality.?Forbes?means that Fitbit can?outrun?Apple in the race to open up the market of blood pressure wearables. To patients, introduction of such devices will mean a future shift from measuring blood pressure on special occasions, even several times a day, to a continuous blood pressure monitoring, where an alarm will alert you if your readings reach over a preset limit.?
At present, however, these devices by?Apple?and?Fitbit?are expected to allow measuring on the go, rather than the continuous measuring.?David Phelan,?Forbes?Senior Contributor, describes the patent filed by Fitbit. It is cuffless, and it has a pressure sensor. The user will place her or his index finger, where the radial artery is, sideways to the sensor. The sensor can measure both systolic and diastolic blood pressure. The heartbeat is measured through a?PPG optical sensor. While?Apple?is working on introducing this functionality to its future?APPLE WATCH, intentions of Fitbit are less clear. However, the main point is who of the two will be the first to introduce a reliable blood pressure measuring wearable, to be approved by the national regulators worldwide.
David Phelan writes: "With so many companies working on simple, accurate blood pressure monitoring on the wrist, it’s beginning to feel like a case of when, not if, it will arrive".
Apple to use lasers in its non-invasive blood glucose monitoring in watches
According to?recent reports?by NextPit, Apple has made significant progress in developing a non-invasive blood sugar level monitoring device for its smartwatches. The device uses a custom photonic chip that shines a laser under the skin to detect glucose levels, which could help prevent high blood sugar levels that can increase the risk of developing hypertension. The prototype device is currently the size of a bulky iPhone, but Apple aims to miniaturize it to the size of a wearable device, such as an Apple Watch. Additionally, Apple has filed patents for a non-invasive blood pressure monitoring system using pressure sensing units along the watchband, although it remains unclear when these features will become available on Apple watches. So far, only?OMRON Group?can boast an FDA approved wearable blood pressure monitor,?Heartguide.
Huawei to launch new blood pressure measurement smartwatch in second half of 2023
Chinese tech giant?Huawei?is preparing to launch a new smartwatch, the?Huawei Watch D2, that can measure blood pressure, in the second half of 2023,?Gismo China?reports. While there is no information available about the upcoming device, it is expected to build on the success of the Huawei Watch D, which includes high-precision pressure sensors, smart blood pressure reminders, and insights into blood pressure-related issues, exercise, and weight. The device also features a powerful ECG analysis capability that provides single-lead ECG measurement. With the new release, consumers can expect even more health-focused features and capabilities from the company.
OPPO patents a wrist-measuring blood pressure device
Tech giant?OPPO?has recently patented an innovative blood pressure measurement device that automatically gauges wrist size, making regular monitoring more convenient for users,?Gismochina?reports. The device, which features two straps connected to a main body, utilizes identification areas to determine the appropriate airbag size based on specific locations on the straps. This unique feature eliminates the need for additional equipment, simplifying the process for regular blood pressure monitoring. Although devoid of a large screen, the device may pave the way for further integration of health measurement technologies in future devices.
Apple has won a patent for a low profile blood pressure measuring
Apple?has been granted a patent for a low-profile blood pressure measurement?system, methods, and cuff design, which could potentially be incorporated into portable multi-function devices,?Patently Apple?reports. The system includes an expandable structure mounted on a rigid surface and is designed for wrist wear. With a controller configuration and multiple expandable cells, the system could communicate with other devices, such as smartphones. Apple's innovative expandable member design suggests the company is working towards integrating health monitoring solutions into their product line, possibly paving the way for more comprehensive health tracking in future wearables.
Samsung's revolutionary OLED screen promises to monitor blood pressure
Samsung Display?has unveiled an innovative OLED display capable of monitoring vital health parameters including blood pressure,?according?to?Android Central. The Sensor OLED display, embedded with a light-sensing organic photodiode (OPD), uses OLED light reflections from the contraction and relaxation of blood vessels in the finger to collect critical cardiovascular data. This technology presents a significant leap from current methods, eliminating the need for a separate fingerprint module beneath the screen. With an increased focus on health, Samsung continues to innovate, providing users with convenient and efficient health monitoring capabilities right at their fingertips.
Samsung improves blood pressure monitoring at Galaxy 4 and 5
Samsung Electronics?has improved the on-demand feature for blood pressure monitoring on their smartwatches, including the Galaxy Watch 4 and the Galaxy Watch 5 series. The new?bioactive sensor?is said to provide more accurate results than earlier versions, Next Pit?reports. To set up the BP monitoring tool, users will need to calibrate their Galaxy smartwatch with a traditional blood pressure cuff, whether digital or analog. After calibration, the user can access the blood pressure monitoring feature on the Samsung Health Monitor app. The feature is available in over 30 countries.